Eric Wenzler (E Wenzler)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 42

Top Venues

Antimicrobial agents and chemotherapy

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Open forum infectious diseases

Microbiology spectrum

University of Illinois at Chicago

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Illinois at Chicago

United States

Infectious Diseases Pharmacotherapy Fellow :: Pharmacy

The Ohio State University Wexner Medical Center

United States

PGY2 Infectious Diseases Resident :: Pharmacy

The Ohio State Univeristy Wexner Medical Center

United States

PGY1 Pharmacy Practice Resident :: Pharmacy

Publications

Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin-clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin-clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Eric Wenzler, Mira Maximos, Tomefa E Asempa, Lauren R Biehle, Audrey N Schuetz, Elizabeth B Hirsch
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy (2023)
Eric Wenzler, Mira Maximos, Tomefa E Asempa, Lauren R Biehle, Audrey N Schuetz, Elizabeth B Hirsch
Antimicrobial Susceptibility Testing: An Updated Primer for Clinicians in the Era of Antimicrobial Resistance: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy (2023)
Kenneth P Klinker, Levita K Hidayat, Eric Wenzler, Joan-Miquel Balada-Llasat, Mary Motyl, C Andrew DeRyke, Karri A Bauer
Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Ravina Kullar, Eric Wenzler, Jose Alexander, Ellie J C Goldstein
Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach. Open forum infectious diseases 9 (5) (2022)
Taylor Abbey, Alesia Vialichka, Michele Jurkovic, Mark Biagi, Eric Wenzler
Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility. Microbiology spectrum 10 (3) (2022)
Alfredo J Mena Lora, Lelia H Chaisson, Eric Wenzler, Scott Borgetti, Susan C Bleasdale
Universal admission testing with a rapid molecular point-of-care test and real-time polymerase chain reaction (PCR) assay for the detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Comparative performance and infection prevention implications. Infection control and hospital epidemiology (2022)
Alesia Vialichka, Mark Biagi, Kevin Meyer, Tiffany Wu, Aisha Shajee, Xing Tan, Eric Wenzler
Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values. Microbiology spectrum 10 (4) (2022)
Pranita D Tamma, Patrick N A Harris, Amy J Mathers, Eric Wenzler, Romney M Humphries
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Eric Wenzler, David Butler, Xing Tan, Takayuki Katsube, Toshihiro Wajima
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy. Clinical pharmacokinetics (2021)
Lauren Andrews, Scott Benken, Xing Tan, Eric Wenzler
Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy. BMC nephrology 22 (1) (2021)
Hannah Whittemore, Andrew K Posen, Erika L Hellenbart, Vicki Groo, Eric Wenzler, Jessica J Tilton
The Impact of Body Weight and Renal Function on the Risk of Bleeding With Direct Oral Anticoagulants in Atrial Fibrillation. The Annals of pharmacotherapy 55 (11) (2021)
Yanqin Huang, Amisha P Rana, Eric Wenzler, Egon Anderson Ozer, Fiorella Krapp, Jürgen B Bulitta, Alan R Hauser, Zackery P Bulman
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae. The Journal of antimicrobial chemotherapy (2021)
Zackery P Bulman, Fiorella Krapp, Nathan B Pincus, Eric Wenzler, Katherine R Murphy, Chao Qi, Egon A Ozer, Alan R Hauser
Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae. mSystems 6 (5) (2021)
Eric Wenzler, Alina Adeel, Tiffany Wu, Michele Jurkovic, Jeremy Walder, Emily Ramasra, Maureen Campion, Jan Cerny, Nicole M Theodoropoulos
Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant Enterococcus faecium Meningitis and Bacteremia. Infectious disease reports 13 (3) (2021)
David A Butler, Mark Biagi, Vikas Gupta, Sarah Wieczorkiewicz, Lisa Young, Ursula Patel, Sandy Naegele, Maressa Santarossa, Amanda Harrington, Mike Postelnick, Mira Suseno, Alyssa Christensen, Julie Giddens, Tim Murrey, Amy Hanson, Sharon Sam, Natasha Pettit, Larry Danziger, Eric Wenzler
Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data. Infection control and hospital epidemiology 41 (12) (2020)
Eric Wenzler, Patrick J Scoble
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam. Infectious diseases and therapy 9 (4) (2020)
Eric Wenzler, Monaz H Engineer, Maidah Yaqoob, Scott T Benken
Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease. TH open : companion journal to thrombosis and haemostasis 4 (4) (2020)
M Biagi, A Vialichka, M Jurkovic, T Wu, A Shajee, M Lee, S Patel, R E Mendes, Eric Wenzler
Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 64 (9) (2020)
Eric Wenzler, Maressa Santarossa, Kevin A Meyer, Amanda T Harrington, Gail E Reid, Nina M Clark, Fritzie S Albarillo, Zackery P Bulman
In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient. Open forum infectious diseases 7 (1) (2020)
M Biagi, D Lamm, K Meyer, A Vialichka, M Jurkovic, S Patel, Rodrigo Elisandro Mendes, Zackery P Bulman, Eric Wenzler
Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 64 (12) (2020)
M Biagi, A Shajee, A Vialichka, M Jurkovic, X Tan, Eric Wenzler
Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens. Antimicrobial agents and chemotherapy 64 (4) (2020)
Eric Wenzler, M Biagi, X Tan, D A Butler
Reply to Baud and Houzé, "Should In Vitro and In Vivo Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?" Antimicrobial agents and chemotherapy 64 (6) (2020)
Eric Wenzler, K M Meyer, S C Bleasdale, M Sikka, R E Mendes, Kristen L Bunnell, M Finnemeyer, S L Rosenkranz, L H Danziger, K A Rodvold
Ex Vivo Urinary Bactericidal Activity and Urinary Pharmacodynamics of Fosfomycin after Two Repeated Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects. Antimicrobial agents and chemotherapy 64 (2) (2020)
M Biagi, X Tan, T Wu, M Jurkovic, A Vialichka, K Meyer, R E Mendes, Eric Wenzler
Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole. Journal of clinical microbiology 58 (2) (2020)
Maressa Santarossa, Emily N Kilber, Eric Wenzler, Fritzie S Albarillo, Ethan J Sterk
BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department. Pharmacy (Basel, Switzerland) 7 (4) (2019)
Melissa Santibañez, Kristen Bunnell, Amanda Harrington, Susan Bleasdale, Eric Wenzler
Association Between Estimated Pharmacokinetic/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections. Open forum infectious diseases 6 (10) (2019)
Natalia M Jasiak-Panek, Eric Wenzler, Shree Patel, James J Thielke, Kristin Progar, Shitalben Patel, Shane Brandt, Yi-Jen Huang, Enrico Benedetti, Patricia M West-Thielke
A randomized, open-label pharmacokinetic trial of tacrolimus extended-release dosing in obese de novo kidney transplant recipients. Clinical transplantation 33 (8) (2019)
Mark Biagi, David Butler, Xing Tan, Samah Qasmieh, Eric Wenzler
A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia. Antibiotics (Basel, Switzerland) 8 (1) (2019)
Eric Wenzler, Susan C Bleasdale, Monica Sikka, Kristen L Bunnell, Matthew Finnemeyer, Susan L Rosenkranz, Larry H Danziger, Keith A Rodvold, null null
Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants. Antimicrobial agents and chemotherapy 62 (8) (2018)
Kristen L Bunnell, Manjunath P Pai, Monica Sikka, Susan C Bleasdale, Eric Wenzler, Larry H Danziger, Keith A Rodvold
Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects. Antimicrobial agents and chemotherapy 62 (4) (2018)
Eric Wenzler, Kristen L Bunnell, Susan C Bleasdale, Scott Benken, Larry H Danziger, Keith A Rodvold
Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration. Antimicrobial agents and chemotherapy 61 (7) (2017)
Margaret M Guinta, Kristen Bunnell, Amanda Harrington, Susan Bleasdale, Larry Danziger, Eric Wenzler
Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile. Annals of clinical microbiology and antimicrobials 16 (1) (2017)
Eric Wenzler, E J Ellis-Grosse, K A Rodvold
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers. Antimicrobial agents and chemotherapy 61 (9) (2017)
Eric Wenzler, Larry H Danziger
Urinary Tract Infections: Resistance Is Futile. Antimicrobial agents and chemotherapy 60 (4) (2016)
Eric Wenzler, Dustin R Fraidenburg, Tonya Scardina, Larry H Danziger
Inhaled Antibiotics for Gram-Negative Respiratory Infections. Clinical microbiology reviews 29 (3) (2016)

Eric Wenzler.css-eqlu8i{font-size:small;padding-left:4px;} (E Wenzler)

Publication Activity (10 Years)

Top Topics

Top Venues

Eric Wenzler (E Wenzler)